Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Increased myeloma risk found to be associated with inherited rare pathogenic mutations in TP53, ATM, CHEK2, KDM1A, and ARID1A, with an enrichment of these variants among individuals with early onset or family history.”
Title: Multiple myeloma risk linked to DNA damage response genes
Authors: Michael Conry, Irina Ostrovnaya, Yelena Kemel, Saloni Sinha, Linda B. Baughn, Brian Avery, Kylee Maclachlan, Victoria Groner, Lauren Banaszak, Aaron Norman, Nicholas J. Boddicker, Alyssa Clay-Gilmour, Shaji Kumar, Ellen Kim, Sita Dandiker, Mitul Waghmare, Susan Slager, Douglas W. Sborov, Judy Garber, Elizabeth E. Brown, Michelle Hildebrandt, Parameshwaran Hari, Nicola Camp, Celine Vachon, Saad Usmani, Kenneth Offit, Vijai Joseph
You can read the Full Article in the Journal of Hematology and Oncology.
You can find more posts featuring Robert Orlowski on OncoDaily.
